Find policies, billing codes, payers, states, and providers

CPT 78130: Red Blood Cell Survival Study, Autologous Radiolabel

CPT code 78130 denotes a diagnostic nuclear medicine study that measures red blood cell lifespan by reinjecting a patient’s own red blood cells labeled with a radiopharmaceutical. This test is used to evaluate hemolytic processes, unexplained anemia, or other conditions affecting erythrocyte survival. Nationally, the procedure is a specialized imaging service performed in hospital outpatient and dedicated nuclear medicine facilities and has implications for diagnostic workups where hemolysis or chronic blood loss is suspected.

Key payers included in the coverage landscape are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context, typical sites of service, and the common modifiers associated with billing this code. The publication also summarizes expected use cases and operational considerations clinicians and billing staff encounter when arranging the study.

The report covers procedural benchmarks, payer coverage patterns, and coding guidance relevant to clinical staff and revenue cycle teams. It highlights factors that commonly affect utilization and reimbursement for diagnostic red blood cell survival testing and provides a national-level reference for institutions that perform nuclear medicine hematology studies.

Customize your policy alerts

Sign up for cpt 78130 policy alerts

Get alerted when payer policies referencing 78130 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

CPT code 78130 describes a diagnostic nuclear medicine procedure in which the provider studies the lifespan of a patient's red blood cells after reinjecting the patient's own red blood cells that have been labeled with a radiopharmaceutical. This service involves tagging autologous erythrocytes with a radiotracer, administering them back to the patient, and performing serial imaging or measurements to determine red blood cell survival.

Service type: Diagnostic nuclear medicine procedure assessing red blood cell survival
Typical site of service: Hospital outpatient imaging departments or nuclear medicine facilities

Find policies, billing codes, payers, states, and providers

CPT 78130: Red Blood Cell Survival Study, Autologous Radiolabel

Customize your policy alerts

Sign up for cpt 78130 policy alerts

Get alerted when payer policies referencing 78130 are released or updated.

Monitor payer policy activity

Receive email alerts as soon as relevant payer policies are published or updated.

Billing Code Overview

Service type: Diagnostic nuclear medicine procedure assessing red blood cell survival
Typical site of service: Hospital outpatient imaging departments or nuclear medicine facilities

Clinical & Coding Specifications

Clinical Context

A 58-year-old patient with chronic anemia of unclear etiology is referred for a red blood cell (RBC) survival study to quantify RBC lifespan and evaluate hemolysis. The procedure begins in a nuclear medicine department. The patient has venous access for blood draw; autologous RBCs are drawn, labeled ex vivo with a technetium-99m or similar radiopharmaceutical, and reinjected. Serial blood samples and/or imaging are obtained over several hours to days to track labeled RBC disappearance. Results are interpreted by a nuclear medicine physician or hematologist and reported to the referring clinician to guide diagnosis of hemolytic anemia, evaluate transfusion efficacy, or assess suspected shortened RBC survival due to alloimmune hemolysis or mechanical destruction from prosthetic valves.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the physician interpretation of the nuclear medicine study separate from the technical component.
`TC`	Technical component	Use when reporting only facility/technical resources without physician interpretation.
`50`	Bilateral procedure	Not typically applicable to this nuclear medicine study; included only if payer policy requires bilateral modifier for paired studies.
`52`	Reduced services	Use when the study is partially reduced or truncated such that full protocol was not performed but service was rendered.
`53`	Discontinued procedure	Use when the study is discontinued after initiation for patient-related or safety reasons.
`59`	Distinct procedural service	Not in the provided modifier list; not included.
`76`	Repeat procedure by same physician	Not in the provided modifier list; not included.
`78`	Unplanned return to the operating/procedure room by the same physician following initial procedure	Use only if an unplanned repeat invasive procedure related to this study occurs; rarely applicable.
`79`	Not in provided list; omitted.
`82`	Assistant surgeon when qualified resident not available	Use only if an assistant surgeon is required and a qualified resident is unavailable; rarely used for this nuclear medicine procedure.
`11`	Office/clinic or inpatient primary provider? (not standard CMS modifier)	Use as appropriate per payer definitions when reporting the primary physician role; many payers accept `26`/`TC` instead.
`22`	Increased procedural services	Use when the study required substantially greater work, complexity, or time than typical and documentation supports unusual effort.
`23`	Unusual anesthesia	Use when general anesthesia or deep sedation was medically necessary for the procedure.
`62`	Two surgeons	Use only if two surgeons are involved and payer requires reporting; rarely applicable.
`80`	Assistant surgeon	Use if an assistant surgeon participated and payer requires the modifier for non-surgical assistance.

Taxonomy Code	Specialty	Notes
208D00000X	Diagnostic Radiology	Nuclear medicine procedures commonly performed by diagnostic radiologists with nuclear medicine training.
2080P0005X	Nuclear Medicine	Specialists in nuclear medicine typically oversee labeling, imaging, and interpretation.
207RH0000X	Hematology	Hematologists commonly order and interpret RBC survival studies for hemolytic disorders.
2084P0800X	Interventional Radiology — Diagnostic	May be involved in vascular access or complex sampling protocols in some centers.
207LC0200X	Internal Medicine	Hospitalists or internists commonly coordinate inpatient studies and follow-up.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D59.9`	Hemolytic anemia, unspecified	Common indication to evaluate for shortened RBC survival and causes of hemolysis.
`D59.1`	Other autoimmune hemolytic anemias	RBC survival studies help quantify hemolysis in autoimmune hemolytic anemia.
`D64.9`	Anemia, unspecified	Used when anemia is present and RBC survival is being assessed as part of the workup.
`D57.0`	Sickle-cell anemia with crisis	In select cases, RBC survival assessment is used to evaluate increased RBC destruction.
`Z51.81`	Encounter for therapeutic drug monitoring	May apply when monitoring effect of therapies intended to reduce hemolysis; supportive context.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`78291`	Directed blood-pool imaging, single area; richiesta for RBC labeling and imaging	Performed when imaging of tagged RBC distribution or pooling is needed in conjunction with RBC survival assessment.
`78300`	Whole body bone scan, if applicable (note: example of nuclear imaging)	Not directly used for RBC survival but listed as an example of nuclear medicine imaging workflows performed in the same department.
`36415`	Collection of venous blood by venipuncture	Required to obtain autologous blood for labeling and for serial blood samples during the survival study.
`99000`	Handling and/or conveyance of specimen (carrier fees) — not current CPT; example only	Some facilities bill specimen handling fees or use facility-specific codes for processing labeled specimens.
`92626`	Not related; included only as placeholder — omitted if strict rules apply.

CPT 78102: Limited-Area Bone Imaging After Radiotracer Administration

CPT-78103-NUCLEAR-MEDICINE-BONE-SCAN

CPT 78103: Nuclear Medicine Bone Scan, Whole Body/Multi-Phase

CPT-78104-WHOLE-BODY-BONE-SCAN

CPT 78104: Whole-Body Bone Scan, Skeletal Scintigraphy

CPT-78110-SINGLE-SAMPLE-PLASMA-VOLUME-DETERMINATION

CPT 78110: Single-Sample Plasma Volume Determination

CPT-78111-PLASMA-VOLUME-MULTIPLE-SAMPLE-METHOD

CPT 78111: Plasma Volume Measurement, Multiple Sample Method

CPT-78120-RADIOLABELED-SINGLE-SAMPLE-RED-CELL-VOLUME

CPT 78120: Single-Sample Radiolabeled Red Cell Volume Determination

CPT-78121-RED-CELL-VOLUME-MULTIPLE-SAMPLE-METHOD

CPT 78121: Red Cell Volume Measurement, Multiple Sample Method

CPT-78122-WHOLE-BLOOD-VOLUME-STUDY-ISOTOPE-DILUTION

CPT 78122: Whole Blood Volume Study via Isotope Dilution

CPT-78140-LIVER-SPLEEN-RADIOLABELED-RED-BLOOD-CELL-SCAN

CPT 78140: Liver and Spleen Scan with Radiolabeled Autologous Red Blood Cells

CPT-78185-SPLEEN-RADIONUCLIDE-SCAN-SPLENIC-IMAGING

CPT 78185: Radionuclide Spleen Study

Showing 1–10 of 13

Frequently Asked Questions

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	Use when reporting only the physician interpretation of the nuclear medicine study separate from the technical component.
`TC`	Technical component	Use when reporting only facility/technical resources without physician interpretation.
`50`	Bilateral procedure	Not typically applicable to this nuclear medicine study; included only if payer policy requires bilateral modifier for paired studies.
`52`	Reduced services	Use when the study is partially reduced or truncated such that full protocol was not performed but service was rendered.
`53`	Discontinued procedure	Use when the study is discontinued after initiation for patient-related or safety reasons.
`59`	Distinct procedural service	Not in the provided modifier list; not included.
`76`	Repeat procedure by same physician	Not in the provided modifier list; not included.
`78`	Unplanned return to the operating/procedure room by the same physician following initial procedure	Use only if an unplanned repeat invasive procedure related to this study occurs; rarely applicable.
`79`	Not in provided list; omitted.
`82`	Assistant surgeon when qualified resident not available	Use only if an assistant surgeon is required and a qualified resident is unavailable; rarely used for this nuclear medicine procedure.
`11`	Office/clinic or inpatient primary provider? (not standard CMS modifier)	Use as appropriate per payer definitions when reporting the primary physician role; many payers accept `26`/`TC` instead.
`22`	Increased procedural services	Use when the study required substantially greater work, complexity, or time than typical and documentation supports unusual effort.
`23`	Unusual anesthesia	Use when general anesthesia or deep sedation was medically necessary for the procedure.
`62`	Two surgeons	Use only if two surgeons are involved and payer requires reporting; rarely applicable.
`80`	Assistant surgeon	Use if an assistant surgeon participated and payer requires the modifier for non-surgical assistance.

Taxonomy Code	Specialty	Notes
208D00000X	Diagnostic Radiology	Nuclear medicine procedures commonly performed by diagnostic radiologists with nuclear medicine training.
2080P0005X	Nuclear Medicine	Specialists in nuclear medicine typically oversee labeling, imaging, and interpretation.
207RH0000X	Hematology	Hematologists commonly order and interpret RBC survival studies for hemolytic disorders.
2084P0800X	Interventional Radiology — Diagnostic	May be involved in vascular access or complex sampling protocols in some centers.
207LC0200X	Internal Medicine	Hospitalists or internists commonly coordinate inpatient studies and follow-up.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`D59.9`	Hemolytic anemia, unspecified	Common indication to evaluate for shortened RBC survival and causes of hemolysis.
`D59.1`	Other autoimmune hemolytic anemias	RBC survival studies help quantify hemolysis in autoimmune hemolytic anemia.
`D64.9`	Anemia, unspecified	Used when anemia is present and RBC survival is being assessed as part of the workup.
`D57.0`	Sickle-cell anemia with crisis	In select cases, RBC survival assessment is used to evaluate increased RBC destruction.
`Z51.81`	Encounter for therapeutic drug monitoring	May apply when monitoring effect of therapies intended to reduce hemolysis; supportive context.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`78291`	Directed blood-pool imaging, single area; richiesta for RBC labeling and imaging	Performed when imaging of tagged RBC distribution or pooling is needed in conjunction with RBC survival assessment.
`78300`	Whole body bone scan, if applicable (note: example of nuclear imaging)	Not directly used for RBC survival but listed as an example of nuclear medicine imaging workflows performed in the same department.
`36415`	Collection of venous blood by venipuncture	Required to obtain autologous blood for labeling and for serial blood samples during the survival study.
`99000`	Handling and/or conveyance of specimen (carrier fees) — not current CPT; example only	Some facilities bill specimen handling fees or use facility-specific codes for processing labeled specimens.
`92626`	Not related; included only as placeholder — omitted if strict rules apply.

CPT 78102: Limited-Area Bone Imaging After Radiotracer Administration

CPT-78103-NUCLEAR-MEDICINE-BONE-SCAN

CPT 78103: Nuclear Medicine Bone Scan, Whole Body/Multi-Phase

CPT-78104-WHOLE-BODY-BONE-SCAN

CPT 78104: Whole-Body Bone Scan, Skeletal Scintigraphy

CPT-78110-SINGLE-SAMPLE-PLASMA-VOLUME-DETERMINATION

CPT 78110: Single-Sample Plasma Volume Determination

CPT-78111-PLASMA-VOLUME-MULTIPLE-SAMPLE-METHOD

CPT 78111: Plasma Volume Measurement, Multiple Sample Method

CPT-78120-RADIOLABELED-SINGLE-SAMPLE-RED-CELL-VOLUME

CPT 78120: Single-Sample Radiolabeled Red Cell Volume Determination

CPT-78121-RED-CELL-VOLUME-MULTIPLE-SAMPLE-METHOD

CPT 78121: Red Cell Volume Measurement, Multiple Sample Method

CPT-78122-WHOLE-BLOOD-VOLUME-STUDY-ISOTOPE-DILUTION

CPT 78122: Whole Blood Volume Study via Isotope Dilution

CPT-78140-LIVER-SPLEEN-RADIOLABELED-RED-BLOOD-CELL-SCAN

CPT 78140: Liver and Spleen Scan with Radiolabeled Autologous Red Blood Cells

CPT-78185-SPLEEN-RADIONUCLIDE-SCAN-SPLENIC-IMAGING

CPT 78185: Radionuclide Spleen Study

Showing 1–10 of 13

Frequently Asked Questions

References

1.CPT® Codes and Descriptions. AAPC. Retrieved Jul 29, 2026.
2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.
3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Jul 29, 2026.

Published by

Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

OpenPayer

CPT 78130: Red Blood Cell Survival Study, Autologous Radiolabel

Sign up for cpt 78130 policy alerts

Billing Code Overview

Catch payer policy changes before they impact reimbursement

Catch payer policy changes before they impact reimbursement

OpenPayer

CPT 78130: Red Blood Cell Survival Study, Autologous Radiolabel

Sign up for cpt 78130 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

References

CPT 78130: Red Blood Cell Survival Study, Autologous Radiolabel

Sign up for cpt 78130 policy alerts

Billing Code Overview

CPT 78130: Red Blood Cell Survival Study, Autologous Radiolabel

Sign up for cpt 78130 policy alerts

Billing Code Overview

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

What does CPT 78130 represent and where is this service usually performed?

Which modifiers are commonly used with 78130 and when should they be applied?

Are there other CPT codes commonly billed with or related to the RBC survival study?

What diagnoses commonly justify ordering an RBC survival study billed with 78130?

Which specialties typically perform or interpret 78130, and which payers are noted as covering this service?

References

Clinical & Coding Specifications

Clinical Context

Coding Specifications

Related Diagnoses

Related CPT Codes

Related Codes

What does CPT 78130 represent and where is this service usually performed?

Which modifiers are commonly used with 78130 and when should they be applied?

Are there other CPT codes commonly billed with or related to the RBC survival study?

What diagnoses commonly justify ordering an RBC survival study billed with 78130?

Which specialties typically perform or interpret 78130, and which payers are noted as covering this service?

References